Article
Do 'cancer mutations' stand only for cancer? Translational and clinical implications.
Trends in molecular medicine - 1 Sept 2023
Mentis Alexios-Fotios A, Papavassiliou Kostas A, Papavassiliou Athanasios G
Abstract excerpt
DNA mutations represent a hallmark of cancer. However, next-generation sequencing (NGS) approaches have revealed that similar somatic mutations are present in healthy tissues as well as in those of several diseases, aging, abnormal vascular formation, and in placental development. These findings call for a reappraisal of whether such mutations are pathognomonic for cancer and provide further mechanistic,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
